AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has issued Duplicate share certificates in lieu of original share certificates AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the copies of newspaper advertisement published in Financial Express (English) and Apla Mahanagar (Marathi), regarding e-voting information for 36th Annual General Meeting of the Company. Aarti Drugs Ltd - 524348 - Notice Of 36Th Annual General Meeting
This is to inform you that 36th Annual General Meeting (''AGM'') of the Company is scheduled to be held on Saturday, September 4, 2021 at 11.30 AM IST through Video Conferencing (''VC'') /Other Audio Visual Means (''OAVM'') AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the copies of newspaper advertisement published in Financial Express (English) and Apla Mahanagar (Marathi), in compliance with the Ministry of Corporate Affairs Circular No. 20/2020 dated May 5, 2020 and Circular No. 02/2021 dated January 13, 2021, intimating inter-alia that 36th Annual General Meeting of the Company will be held on Saturday, September 4, 2021 at 11:30 AM IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM). Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has issued Duplicate share certificates in lieu of original share certificates
Buy Aarti Drugs; target of Rs 844: Anand Rathi
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 844 in its research report dated July 28, 2021. Aarti Drugs Ltd - 524348 - Intimation Under Regulation 31A(8)(B) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015.
In accordance with Regulation 31A(8)(b) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, the Extract of the minutes of the meeting of the Board of Directors approving the request for Re-classification of shares is attached herewith.
Earnings Call for Q1FY22 of Aarti Drugs
Conference Call with Aarti Drugs Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith Results Presentation for the Quarter ended June 30, 2021 for your records.